Search
for
Sort by
Research 421–450 of 1000+
- [Skin changes from taking hormonal contraceptives].
- Minoxidil Ingestion in a Toddler
- Hair and Nail Conditions: Alopecia Evaluation.
- Diagnosis and Management of Female Pattern Hair Loss
- Disorders of the Hair and Nails
- Male Pattern Alopecia Regrowth Following Topical Fluorouracil Therapy
- Molecular monitoring of short- and long-term transcriptional effects of hair growth stimulating agents
- Trichoscopic Hallmarks in Non-cicatricial and Cicatricial Alopecia in Indian Population: A Narrative Review
- Sisaipho Revisited: Inverse Ophiasis or More than That?
- Distinguishing Gender Identity From Biological Sex in Dermatologic Health Care: Methods, Harms, and Paths Forward
- Alopecia – focus on negative emotional impact
- Alopecia androgenética: aspectos etiopatogênicos, métodos diagnósticos e condutas terapêuticas
- Male Androgenetic Alopecia
- Monotherapy with platelet-rich plasma for male and female pattern baldness: protocol for a systematic review
- The Microbiome in Hair Disorders
- Application of phototherapy in alopecia
- Price discrimination across indications in the pharmaceutical industry: The case of finasteride
- 저용량 Finasteride(1mg/일, Propeciaⓡ)투여 후 악화된 일측성의 원발성 여성형 유방 1예
- A Method for Evaluating and Treating the Temporal Peak Region in Patients with Male Pattern Baldness
- News in brief
- Clues to the cause of male pattern baldness
- Commentary on: The Effects of Lower vs Higher Cell Number of Platelet-Rich Plasma (PRP) in Hair Density and Diameter in Androgenetic Alopecia (AGA): A Randomized, Double-Blinded, Placebo, Parallel-Group Half-Scalp IRB Study
- FINASTERIDE AS A TREATMENT FOR MALE ANDROGENETIC ALOPECIA
- Cosmeceutical Treatments for Androgenetic Alopecia
- News updates
- Scalp Hair Regrowth in Hormone-Treated Transgender Woman
- EEMCO Guidance for the in vivo Assessment of Skin Greasiness
- Microneedling: Where do we stand now? A systematic review of the literature
- GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk
- Association of Benign Prostatic Hyperplasia with Male Pattern Baldness